Coastal Investment Advisors, Inc. Alaunos Therapeutics, Inc. Transaction History

Coastal Investment Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 13, 2021	SELL	$2.09 - $3.09 $22,049 - $32,599	-10,550 Closed	0 $0
Q1 2020 Apr 23, 2020	SELL	$1.9 - $4.98 $1,900 - $4,980	-1,000 Reduced 8.66%	10,550 $26,000
Q4 2019 Feb 05, 2020	BUY	$3.95 - $5.35 $3,950 - $5,350	1,000 Added 9.48%	11,550 $59,000
Q3 2019 Oct 18, 2019	BUY	$4.13 - $6.94 $35,311 - $59,337	8,550 Added 427.5%	10,550 $44,000
Q2 2019 Aug 01, 2019	BUY	$3.98 - $6.2 $7,960 - $12,400	2,000 New	2,000 $12,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $424M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Coastal Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Coastal Investment Advisors, Inc. with notifications on news.